Outputs (7)

Increasing adherence in therapies and polypharmacy in Europe: EIP on AHA Action Group A1 activities toward integrated care information systems and self-management applications (2016)
Journal Article
Fico, G., Cena, C., Mair, A., Monaco, A., Costa, E., Giardini, A., & Papadopoulos, H. (2016). Increasing adherence in therapies and polypharmacy in Europe: EIP on AHA Action Group A1 activities toward integrated care information systems and self-managemen

No abstract available.

Polypharmacy management programmes: the SIMPATHY Project (2016)
Journal Article
Fernandez-Llimos, F., & Mair, A. (2017). Polypharmacy management programmes: the SIMPATHY Project. European Journal of Hospital Pharmacy, 24(1), 5-6. https://doi.org/10.1136/ejhpharm-2016-001044

No abstract available.

Polypharmacy and Adherence: Key Components of Integrated Care Findings from the SIMPATHY Project (2016)
Presentation / Conference Contribution
Mair, A., McIntosh, J., Codina, C., Molist, N., & Alonso, A. (2016). Polypharmacy and Adherence: Key Components of Integrated Care Findings from the SIMPATHY Project. International journal of integrated care, 16(6), A190. https://doi.org/10.5334/ijic.2738

Context, aims and objectives: As many as half of all patients with chronic conditions are using their medicines in a way that is not fully effective, resulting in sub-optimal treatment and subsequent increases in hospitalisations and emergency depart... Read More about Polypharmacy and Adherence: Key Components of Integrated Care Findings from the SIMPATHY Project.

The use of PESTEL as a change management tool to inform change management of polypharmacy and adherence within SIMPATHY program (2016)
Presentation / Conference Contribution
Geitona, M., Vontetsianos, T., Mair, A., Mc Kenzie, D., Michael, N., Kousoulakou, H., …Balasopoulou, A. (2016). The use of PESTEL as a change management tool to inform change management of polypharmacy and adherence within SIMPATHY program. Internationa

Introduction: Polypharmacy and medication adherence in the older populationwith multiple chronic conditionsare significant public health issues across all the European Union (EU) countries. SIMPATHY (Stimulating Innovation Management of Polypharmacy... Read More about The use of PESTEL as a change management tool to inform change management of polypharmacy and adherence within SIMPATHY program.

Guidance to manage inappropriate polypharmacy in older people: systematic review and future developments (2016)
Journal Article
Lewek, P., MacLure, K., McIntosh, J., Alonso, A., Kardas, P., Wilson, M., …Stewart, D. (2016). Guidance to manage inappropriate polypharmacy in older people: systematic review and future developments. Expert Opinion on Drug Safety, 16(2), 203-213. https

Introduction: Single disease state led evidence-based guidelines do not provide sufficient coverage of issues of multimorbidities, with the cumulative impact of recommendations often resulting in overwhelming medicines burden. Inappropriate polypharm... Read More about Guidance to manage inappropriate polypharmacy in older people: systematic review and future developments.

Polypharmacy management: an under recognized public health issue (2016)
Presentation / Conference Contribution
McIntosh, J., Alonso, A., Codina, C., & Mair, A. (2016). Polypharmacy management: an under recognized public health issue. European Journal of Public Health, 26(suppl_1), https://doi.org/10.1093/eurpub/ckw174.050

Background Multiple chronic diseases in individuals increase the risk of inappropriate polypharmacy, an under recognised public health issue. SIMPATHY (Stimulating Innovation Management of Polypharmacy and Adherence in The Elderly) aims to develop c... Read More about Polypharmacy management: an under recognized public health issue.

Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5) (2016)
Journal Article
Bousquet, J., Farrell, J., Crooks, G., Hellings, P., Bel, E. H., Bewick, M., …Mercier, J. (2016). Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Are

Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) focuses on the integrated care of chronic diseases. Area 5 (Care Pathways) was initiated using chronic respiratory diseases as a model. The chronic respir... Read More about Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).